The use of smell identification tests in the diagnosis of Parkinson's disease in Brazil

Movement Disorders

Volumn 23, Issue 16, 2008, Pages 2328-2334

  Silveira Moriyama, Laura ^a   de Jesus Carvalho, Margarete ^b   Katzenschlager, Regina ^c   Petrie, Aviva ^d   Ranvaud, Ronald ^b   Barbosa, Egberto Reis ^b   Lees, Andrew J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c DANUBE HOSPITAL   (Austria)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Olfaction; Parkinson's disease; Smell; Sniffin sticks; UPSIT

Indexed keywords

ADULT; ARTICLE; BRAZIL; COGNITION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OLFACTORY DISCRIMINATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROBABILITY; RELIABILITY; SENSITIVITY AND SPECIFICITY; SMELLING; VALIDATION PROCESS;

ADULT; BRAZIL; DISCRIMINATION (PSYCHOLOGY); FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ODORS; PARKINSON DISEASE; SMELL;

EID: 61449220049     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22241     Document Type: Article

References (40)

1. McKinnon JH, Demaerschalk BM, Caviness JN, et al. Sniffing out Parkinson disease: can olfactory testing differentiate Parkinsonian disorders? Neurologist 2007;13:382-385.
2. Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988;38:1237-1244.
3. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1992; 55:138-142.
4. Hawkes CH, Shephard BC, Daniel SE. Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;62: 436-446.
5. Barz S, Hummel T, Pauli E, Majer M, Lang CJ, Kobal G. Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson's disease. Neurology 1997;49:1424-1431.
6. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992;42:1142-1146.
7. Brucki SM, Nitrini R, Caramelli P, Bertolucci PH, Okamoto IH. [Suggestions for utilization of the mini-mental state examination in Brazil]. Arq Neuropsiquiatr 2003;61:777-781.
8. Barbosa MT, Caramelli P, Maia DP, et al. Parkinsonism and Parkinson's disease in the elderly: a community-based survey in Brazil (the Bambui study). Mov Disord 2006;21:800-808.
9. Brazilian Institute for Geography and Statistics (IBGE). Brasil em sintese. http://www.ibge.gov.br/brasil_em_sintese/tabelas/ populacao_tabela01.htm Accessed in April 2008.
10. Haerer AF, Anderson DW, Schoenberg BS. Prevalence of essential tremor. Results from the Copiah County study. Arch Neurol 1982;39:750-751.
11. Louis ED, Marder K, Cote L, et al. Differences in the prevalence of essential tremor among elderly African Americans, whites, and Hispanics in northern Manhattan, NY. Arch Neurol 1995; 52:1201-1205.
12. Benamer HT, Oertel WH, Patterson J, et al. Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders, Part 1: Baseline and 3-month observations. Mov Disord 2003;18:977-984.
13. Richards M, Stern Y, Mayeux R. Subtle extrapyramidal signs can predict the development of dementia in elderly individuals. Neurology 1993;43:2184-2188.
14. Hoglinger GU, Rissling I, Metz A, et al. Enhancing recognition of early Parkinsonism in the community. Mov Disord 2004; 19:505-512.
15. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39.
16. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
17. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001; 57:1497-1499.
18. Jennings DL, Seibyl JP, Oakes D, Eberly S, Murphy J, Marek K. (123I) beta-CIT and single-photon emission computed tomographic imaging vs. clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis. Arch Neurol 2004;61: 1224-1229.
19. Doty RL, Bromley SM, Stern MB. Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria. Neurodegeneration 1995;4:93-97.
20. Khan NL, Katzenschlager R, Watt H, et al. Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease. Neurology 2004;62:1224-1226.
21. Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. 'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 1997;22:39-52.
22. Hummel T, Kobal G, Gudziol H, kay-Sim A. Normative data for the "Sniffin' Sticks" including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 2007;264:237-243.
23. Doty RL. The smell identification test administration manual, 3rd ed. Haddon Heights: Sensonics; 1995.
24. Hawkes CH. Parkinson's disease and aging: same or different process? Mov Disord 2008;23:47-53.
25. Katotomichelakis M, Balatsouras D, Tripsianis G, et al. The effect of smoking on the olfactory function. Rhinology 2007;45: 273-280.
26. Frye RE, Schwartz BS, Doty RL. Dose-related effects of cigarette smoking on olfactory function. JAMA 1990;263:1233-1236.
27. Muller A, Reichmann H, Livermore A, Hummel T. Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients. J Neural Transm 2002;109:805-811.
28. Tissingh G, Berendse HW, Bergmans P, et al. Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Mov Disord 2001;16:41-46.
29. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1992; 55:138-142.
30. Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988;38:1237-1244.
31. Quinn NP, Rossor MN, Marsden CD. Olfactory threshold in Parkinson's disease. J Neurol Neurosurg Psychiatry 1987;50:88-89.
32. Ward CD, Hess WA, Calne DB. Olfactory impairment in Parkinson's disease. Neurology 1983;33:943-946.
33. Katzenschlager R, Zijlmans J, Evans A, Watt H, Lees AJ. Olfactory function distinguishes vascular parkinsonism from Parkinson's disease. J Neurol Neurosurg Psychiatry 2004;75:1749-1752.
34. Lee PH, Yeo SH, Yong SW, Kim YJ. Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism. J Neurol Neurosurg Psychiatry 2007;78:1250-1252.
35. Applegate LM, Louis ED. Essential tremor: mild olfactory dysfunction in a cerebellar disorder. Parkinsonism Relat Disord 2005;11:399-402.
36. Busenbark KL, Huber SJ, Greer G, Pahwa R, Koller WC. Olfactory function in essential tremor. Neurology 1992;42:1631-1632.
37. Hawkes C, Shah M, Findley L. Olfactory function in essential tremor: a deficit unrelated to disease duration or severity. Neurology 2003;61:871-872.
38. Louis ED, Bromley SM, Jurewicz EC, Watner D. Olfactory dysfunction in essential tremor: a deficit unrelated to disease duration or severity. Neurology 2002;59:1631-1633.
39. Louis ED, Jurewicz EC. Olfaction in essential tremor patients with and without isolated rest tremor. Mov Disord 2003;18:1387-1389.
40. Shah M, Findley L, Muhammed N, Hawkes C. Olfaction is normal in essential tremor and can be used to distinguish it from parkinson disease. Clinical Neurophysiol 2007;118:e173.